Biotechnological developments have led to an increased number of recombinant proteins or antibodies in drug development that offer high potential in various diseases, such as cancer, growth disturbances and diabetes.
François Becher
Advertisement
Articles by François Becher
Advertisement
Latest Updated Articles
Bioanalysis of recombinant proteins by mass spectrometryPublished: September 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
2
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
3
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
4
Defining An Agitation Model for Early-Stage, High Concentration Biologics Formulation Development
5
